SymBiosis is an investment firm focused on advancing biotherapeutics innovations for serious and life-threatening diseases. The firm invests in groundbreaking medicines across disease area, financing stage, and geography, with a focus on programs in, or about to enter, human trials. SymBiosis currently manages a portfolio of more than 30 investments and has significant, long-term capital commitments to fund future investments. 

SymBiosis

Symbiosis Corp. is a venture capital firm that specializes in providing strategic guidance and operational support to startups and growth-stage companies. The firm leverages a network of experienced operating advisors to offer mentorship and expertise in various industries, helping portfolio companies scale and succeed in competitive markets.

VC:SYMBIOSIS

Symbiosis Corp.

Filings Not Available